Investigating the in vitro antibacterial, antibiofilm, antioxidant, anticancer and antiviral activities of zinc oxide nanoparticles biofabricated from Cassia javanica

• DOI: 10.1371/journal.pone.0310927
• Publication Date: 2024-10-01T17:26:08Z
• Authors: Mohammed S. Almuh...; Mohammed H. Alruh...; Mohamed K. Y. Sol...; Muyassar K. Tarab...; Ruba A. Ashy; Amna A. Saddiq; Samy Selim; Yasir Alruwaili; Salem S. Salem
• Keywords: Methicillin-Resistant Staphylococcus aureus; Plant Extracts; Cassia; Metal Nanoparticles; Antineoplastic Agents; Microbial Sensitivity Tests; Antiviral Agents; Antioxidants; Anti-Bacterial Agents; Biofilms; Chlorocebus aethiops; Humans; Animals; Nanoparticles; Zinc Oxide; Vero Cells; Research Article

It is thought to be risk-free, environmentally benign, and safe for biological processes to produce zinc oxide nanoparticles from renewable resources. This study examined Cassia javanica’s ability to create ZnONPs. The generated ZnONPs were analyzed using a variety of techniques, such as TEM, FTIR spectroscopy, UV-Vis spectroscopy, and XRD analysis. The antibacterial potential of ZnONPs has been investigated using both Agar well diffusion and microtitreplate (MTP) methods. One method used to evaluate ZnONPs’ capacity to scavenge free radicals at different concentrations was the DPPH method. The permanent zinc oxide (ZnO) shape and the naturally occurring crystal structure of ZnONPs were validated by the XRD data. ZnONPs showed antibacterial activity with MICs of 31.7 μg/mL toward Bacillus subtilis, 62.5 μg/mL for Salmonella typhimurium, Escherichia coli while Clostridium sporogenes and Bacillus pumilus was 125μg/mL. Furthermore, ZnONPs demonstrated a range of antibiofilm activities toward Staphylococcus aureus (MRSA). ZnONPs showed an intriguing antioxidant capacity, achieving IC50 of 109.3 μg/ml μg/mL. Additionally, ZnONPs demonstrated low toxic effect on Vero cell with IC50 154.01 μg/mL as well as possible anticancer action when applied to the carcinoma cell lines HepG2 with IC50 of 47.48 μg/mL. Furthermore, ZnONPs at 62.5 μg/mL had a promising antiviral impact against HSV1 and COX B4, with antiviral activities of 75.4% and 65.8%, respectively.